Skip to content

POGO® Automatic Blood Glucose Monitoring System Clinical Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02333864
Enrollment
287
Registered
2015-01-07
Start date
2014-12-31
Completion date
2015-03-31
Last updated
2015-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Brief summary

The purpose of this study is to determine if the POGO® system delivers accurate blood glucose readings in the hands of the lay user and assess the POGO® system accuracy when used by trained health care professionals.

Detailed description

Subjects will review labeling materials and self-test using the POGO® system. An HCP-assisted test also will be performed; both tests will be compared to a fingerstick capillary sample run on a YSI reference glucose analyzer. Subjects will complete questionnaires on labeling comprehension and POGO® usability.

Interventions

DEVICEPOGO® BGMS

SMBG

Sponsors

Intuity Medical, Inc
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Be diagnosed with diabetes * Be 18 years of age or older * Be able to read, write, and understand English fluently * Be able and willing to give written informed consent and have provided signed, written consent

Exclusion criteria

* Any condition which in the opinion of the Investigator may place the subject or site personnel at excessive risk * A physical condition or limitation that prevents the subject from reading the labeling and using a BGMS on their own * Previous experience with the POGO® BGMS * Formal experience with clinical (medical) laboratory equipment or formal training in a relevant medical field

Design outcomes

Primary

MeasureTime frameDescription
Accuracy Validation of the POGO® BGMS: Minimum outcome of 95% of results within 20% of reference measurement.Blood glucose measured at time of single visit for each subject, endpoint evaluated at completion of study (approximately four months after initiation.)Lay-user accuracy
Accuracy Verification of the POGO® BGMS: Minimum outcome of 95% of results within 20% of reference measurement.Blood glucose measured at time of single visit for each subject, endpoint evaluated at completion of study (approximately four months after initiation.)HCP accuracy

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026